Molecule2Market (M2M) is a boutique Australian CRO. Co-founder and Director of M2M, Anne leads a highly experienced team of clinical research professionals dedicated to advancing the research and development of innovative medical treatments. Combining our expertise and experience, we provide high quality services across all phases of clinical research and a broad range of therapeutic areas.